EXAS EXACT SCIENCES CORP revenue, earnings and financials
For the quarter ended December 31, 2025, EXACT SCIENCES CORP reported revenue of $878M (up 23.1% from a year earlier), net income of −$86.0M and diluted EPS of −$0.45; over the last four quarters revenue was $3.25B and net income −$208M; for the fiscal year ended December 2025 revenue was $3.25B, up 17.7% on the year before.
EXAS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $3.25B, gross profit $2.26B, operating income −$206M, net income −$208M (margin -6.4%), EPS −$1.10
- Fiscal year ended Dec 2024: revenue $2.76B, gross profit $1.92B, operating income −$1.05B, net income −$1.03B (margin -37.3%), EPS −$5.59
- Fiscal year ended Dec 2023: revenue $2.50B, gross profit $1.76B, operating income −$215M, net income −$204M (margin -8.2%), EPS −$1.13
- Fiscal year ended Dec 2022: revenue $2.08B, gross profit $1.42B, operating income −$594M, net income −$624M (margin -29.9%), EPS −$3.54
- Fiscal year ended Dec 2021: revenue $1.77B, gross profit n/a, operating income −$856M, net income −$596M (margin -33.7%), EPS −$3.48
EXAS quarterly revenue and earnings
- Quarter ended Dec 31, 2025 (from the annual report): revenue $878M (up 23.1% year over year), net income −$86.0M, EPS −$0.45
- Quarter ended Sep 30, 2025: revenue $851M (up 20.0% year over year), net income −$19.6M, EPS −$0.10
- Quarter ended Jun 30, 2025: revenue $811M (up 16.0% year over year), net income −$1.19M, EPS −$0.01
- Quarter ended Mar 31, 2025: revenue $707M (up 10.9% year over year), net income −$101M, EPS −$0.54
- Quarter ended Dec 31, 2024: revenue $713M (up 10.3% year over year), net income −$865M, EPS −$4.67
- Quarter ended Sep 30, 2024: revenue $709M (up 12.8% year over year), net income −$38.2M, EPS −$0.21
- Quarter ended Jun 30, 2024: revenue $699M (up 12.4% year over year), net income −$15.8M, EPS −$0.09
- Quarter ended Mar 31, 2024: revenue $638M (up 5.8% year over year), net income −$110M, EPS −$0.60
- Quarter ended Dec 31, 2023: revenue $647M (up 17.0% year over year), net income −$49.8M, EPS −$0.27
- Quarter ended Sep 30, 2023: revenue $628M (up 20.1% year over year), net income $794K, EPS $0.00
- Quarter ended Jun 30, 2023: revenue $622M (up 19.3% year over year), net income −$81.0M, EPS −$0.45
- Quarter ended Mar 31, 2023: revenue $602M (up 23.8% year over year), net income −$74.2M, EPS −$0.42
- Quarter ended Dec 31, 2022 (from the annual report): revenue $553M (up 16.7% year over year), net income −$128M, EPS −$0.72
- Quarter ended Sep 30, 2022: revenue $523M (up 14.6% year over year), net income −$149M, EPS −$0.84
- Quarter ended Jun 30, 2022: revenue $522M (up 20.0% year over year), net income −$166M, EPS −$0.94
- Quarter ended Mar 31, 2022: revenue $487M (up 21.0% year over year), net income −$181M, EPS −$1.04
- Quarter ended Dec 31, 2021: revenue $474M, net income −$221M, EPS −$1.28
- Quarter ended Sep 30, 2021: revenue $456M, net income −$167M, EPS −$0.97
- Quarter ended Jun 30, 2021: revenue $435M, net income −$177M, EPS −$1.03
- Quarter ended Mar 31, 2021: revenue $402M, net income −$31.2M, EPS −$0.18
EXAS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $491M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $211M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow $156M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$224M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$102M, share buybacks n/a
EXAS balance sheet
- Dec 31, 2025: cash $956M, total assets $5.86B, total liabilities $3.46B, shareholders' equity $2.40B
- Sep 30, 2025: cash $789M, total assets $5.90B, total liabilities $3.40B, shareholders' equity $2.50B
- Jun 30, 2025: cash $657M, total assets $5.80B, total liabilities $3.33B, shareholders' equity $2.47B
- Mar 31, 2025: cash $347M, total assets $5.71B, total liabilities $3.31B, shareholders' equity $2.40B
- Dec 31, 2024: cash $601M, total assets $5.93B, total liabilities $3.53B, shareholders' equity $2.40B
- Sep 30, 2024: cash $589M, total assets $6.75B, total liabilities $3.54B, shareholders' equity $3.21B
- Jun 30, 2024: cash $530M, total assets $6.67B, total liabilities $3.48B, shareholders' equity $3.19B
- Mar 31, 2024: cash $347M, total assets $6.38B, total liabilities $3.24B, shareholders' equity $3.13B
What is EXAS's revenue?
EXACT SCIENCES CORP reported $3.25B of revenue over its last four quarters, through December 31, 2025.
Is EXAS profitable?
No. EXACT SCIENCES CORP lost $208M over the last four quarters.
What is EXAS's EPS?
Diluted earnings per share over the last four quarters were −$1.10; −$0.45 in the latest quarter.